Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Diagnostic Imaging

Free Subscription Articles published in Lancet Retrieve available abstracts of 43 articles: HTML format

Single Articles

February 2026
1. HARADA-SHOJI N, Suzuki A, Ishida T, Yamamoto S, et al
   Cumulative incidence of advanced breast cancer in women aged 40-49 years in the Japan Strategic Anti-cancer Randomised Trial (J-START) of adjunctive ultrasonography: a prespecified secondary analysis.
   Lancet. 2026;407:784-793.
   PubMed     Abstract available
   
   
   
2. SEELY JM, Gordon PB
   Supplemental ultrasound screening lowers advanced breast cancers.
   Lancet. 2026;407:737-738.
   PubMed    
   
   
   January 2026
3. GOMMERS J, Hernstrom V, Josefsson V, Sartor H, et al
   Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy tria
   Lancet. 2026;407:505-514.
   PubMed     Abstract available
   
   
   December 2025
4. GOADSBY J, Syngelaki A, Magee LA, von Dadelszen P, et al
   Scheduled birth at term for the prevention of pre-eclampsia (PREVENT-PE): an open-label randomised controlled trial.
   Lancet. 2025 Dec 4:S0140-6736(25)01207-3. doi: 10.1016/S0140-6736(25)01207.
   PubMed     Abstract available
   
   
   November 2025
5. VAN DER BIJL P, Gulati M, Saraste A, Marwick T, et al
   Contemporary, non-invasive imaging diagnosis of chronic coronary artery disease.
   Lancet. 2025;406:2577-2587.
   PubMed     Abstract available
   
   
   May 2025
6. GILBERT FJ, Payne NR, Allajbeu I, Yit L, et al
   Comparison of supplemental breast cancer imaging techniques-interim results from the BRAID randomised controlled trial.
   Lancet. 2025 May 21:S0140-6736(25)00582-3. doi: 10.1016/S0140-6736(25)00582.
   PubMed     Abstract available
   
   
   
7. HOUSSAMI N
   Breast cancer screening at a crossroads: supplemental imaging for dense breasts.
   Lancet. 2025 May 21:S0140-6736(25)00803-7. doi: 10.1016/S0140-6736(25)00803.
   PubMed    
   
   
   March 2025
8. SERRUYS PW, Tsai TY, Revaiah PC
   Achieve more with less metal in PCI: angiography-derived FFR, intravascular ultrasound, or both?
   Lancet. 2025 Mar 28:S0140-6736(25)00576-8. doi: 10.1016/S0140-6736(25)00576.
   PubMed    
   
   
   
9. HU X, Zhang J, Yang S, Jiang J, et al
   Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease (FLAVOUR II): a multicentre, randomised, non-inferiority trial.
   Lancet. 2025 Mar 28:S0140-6736(25)00504-5. doi: 10.1016/S0140-6736(25)00504.
   PubMed     Abstract available
   
   
   
10. FEARON WF, Zimmermann FM, Ding VY, Takahashi K, et al
    Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial.
    Lancet. 2025 Mar 28:S0140-6736(25)00505-7. doi: 10.1016/S0140-6736(25)00505.
    PubMed     Abstract available
    
    
    
11. ELIA-ZUDAIRE O, Tirado-Galindo M
    Towards a European imaging infrastructure for Alzheimer's disease.
    Lancet. 2025;405:779.
    PubMed    
    
    
    February 2025
12. ARGENTESI G, Wu X, Ney A, Goodchild E, et al
    Endoscopic, ultrasound-guided, radiofrequency ablation of aldosterone-producing adenomas (FABULAS): a UK, multicentre, prospective, proof-of-concept trial.
    Lancet. 2025 Feb 7:S0140-6736(24)02755-7. doi: 10.1016/S0140-6736(24)02755.
    PubMed     Abstract available
    
    
    
13. DUNN JA, Donnelly P, Elbeltagi N, Marshall A, et al
    Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trial.
    Lancet. 2025;405:396-407.
    PubMed     Abstract available
    
    
    January 2025
14. WILLIAMS MC, Wereski R, Tuck C, Adamson PD, et al
    Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART randomised controlled trial in Scotland.
    Lancet. 2025;405:329-337.
    PubMed     Abstract available
    
    
    
15. VILLINES TC
    Durability of patient benefit from CT-guided chest pain management.
    Lancet. 2025;405:278-279.
    PubMed    
    
    
    
16. NAVARRO-COMPAN V, Sepriano A, Capelusnik D, Baraliakos X, et al
    Axial spondyloarthritis.
    Lancet. 2025;405:159-172.
    PubMed     Abstract available
    
    
    October 2024
17. ANDERSEN BK, Sejr-Hansen M, Maillard L, Campo G, et al
    Quantitative flow ratio versus fractional flow reserve for coronary revascularisation guidance (FAVOR III Europe): a multicentre, randomised, non-inferiority trial.
    Lancet. 2024 Oct 29:S0140-6736(24)02175-5. doi: 10.1016/S0140-6736(24)02175.
    PubMed     Abstract available
    
    
    August 2024
18. CASADO-NARANJO I, Portilla-Cuenca JC, Duarte-Martin JJ, Moyano-Calvente SL, et al
    Multiple intracerebral haemorrhages and ubiquitous brain microbleeds in a patient with Down syndrome: cerebral amyloid angiopathy.
    Lancet. 2024;404:e4.
    PubMed    
    
    
    
19. HONG SJ, Lee SJ, Lee SH, Lee JY, et al
    Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea.
    Lancet. 2024 Aug 30:S0140-6736(24)01454-5. doi: 10.1016/S0140-6736(24)01454.
    PubMed     Abstract available
    
    
    
20. MAMAS MA, Mintz GS
    Optical coherence tomography imaging for complex percutaneous coronary intervention.
    Lancet. 2024 Aug 30:S0140-6736(24)01593-9. doi: 10.1016/S0140-6736(24)01593.
    PubMed    
    
    
    
21. FIGUERAS F, Rial-Crestelo M, Gratacos E
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial - Authors' reply.
    Lancet. 2024;404:751-752.
    PubMed    
    
    
    
22. GILES-CLARK HJ, Rolnik DL, Hodges RJ, Skinner SM, et al
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
    Lancet. 2024;404:750.
    PubMed    
    
    
    
23. BACON I, Hezelgrave NL, Cerdeira AS, Mylrea-Foley B, et al
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
    Lancet. 2024;404:750-751.
    PubMed    
    
    
    
24. KAMIHARA Y, Nagase H, Ishikawa H
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
    Lancet. 2024;404:749-750.
    PubMed    
    
    
    
25. MEIJERINK L, Terstappen F, Depmann M, Bekker M, et al
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
    Lancet. 2024;404:749.
    PubMed    
    
    
    
26. BORNSTEIN E, Vintzileos A
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
    Lancet. 2024;404:748-749.
    PubMed    
    
    
    
27. FERREIRA J, Velazquez PP, Zaromytidou M, Montrasio G, et al
    Fibrofatty involution of rhabdomyomas: a longitudinal series of cardiac MRI studies in a patient with possible tuberous sclerosis complex.
    Lancet. 2024;404:692-693.
    PubMed    
    
    
    
28. MESSAS E, Ijsselmuiden A, Trifunovic-Zamaklar D
    Limitations of non-invasive ultrasound therapy for valve stenosis - Authors' reply.
    Lancet. 2024;404:654.
    PubMed    
    
    
    
29. KOMAMURA K, Miyake H, Kobayashi K, Iwase M, et al
    Limitations of non-invasive ultrasound therapy for valve stenosis.
    Lancet. 2024;404:653-654.
    PubMed    
    
    
    
30. OU D, Hu C, Huang S
    Limitations of non-invasive ultrasound therapy for valve stenosis.
    Lancet. 2024;404:653.
    PubMed    
    
    
    July 2024
31. LI M, Kim JB, Sastry BKS, Chen M, et al
    Infective endocarditis.
    Lancet. 2024;404:377-392.
    PubMed     Abstract available
    
    
    
32. BHIDE P, Chan DYL, Lanz D, Alqawasmeh O, et al
    Clinical effectiveness and safety of time-lapse imaging systems for embryo incubation and selection in in-vitro fertilisation treatment (TILT): a multicentre, three-parallel-group, double-blind, randomised controlled trial.
    Lancet. 2024;404:256-265.
    PubMed     Abstract available
    
    
    May 2024
33. DE OLIVEIRA FRANCO A, Uberti Dos Santos V, von Ameln Lovison O, Zavascki AP, et al
    Invasive liver abscess syndrome with central nervous system involvement caused by hypermucoviscous Klebsiella pneumoniae: positive string test.
    Lancet. 2024;403:2257-2258.
    PubMed    
    
    
    
34. TOPOL EJ
    AI-enabled opportunistic medical scan interpretation.
    Lancet. 2024;403:1842.
    PubMed    
    
    
    
35. PONSSEN D, Joseph AA, Neef NE, Frahm J, et al
    Visualising the dynamic morphology of stuttering using real-time MRI.
    Lancet. 2024;403:1789-1790.
    PubMed    
    
    
    April 2024
36. LI X, Ge Z, Kan J, Anjum M, et al
    Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial.
    Lancet. 2024 Apr 5:S0140-6736(24)00282-4. doi: 10.1016/S0140-6736(24)00282.
    PubMed     Abstract available
    
    
    
37. DEN DEKKER WK
    Is intravascular imaging the future of percutaneous coronary intervention?
    Lancet. 2024 Apr 5:S0140-6736(24)00430-6. doi: 10.1016/S0140-6736(24)00430.
    PubMed    
    
    
    March 2024
38. RAKOCZY EP
    The promise of long-term treatment for neovascular age-related macular degeneration.
    Lancet. 2024 Mar 27:S0140-6736(24)00428-8. doi: 10.1016/S0140-6736(24)00428.
    PubMed    
    
    
    
39. BURKI T
    Research in Focus: Gates MRI.
    Lancet. 2024;403:1126.
    PubMed    
    
    
    
40. CHEW EY
    Increasing concentrations of intravitreal therapies for neovascular age-related macular degeneration.
    Lancet. 2024 Mar 7:S0140-6736(24)00229-0. doi: 10.1016/S0140-6736(24)00229.
    PubMed    
    
    
    
41. GABRIELLE PH, Creuzot-Garcher C
    Can high-dose aflibercept satisfy unmet treatment needs in diabetic macular oedema?
    Lancet. 2024 Mar 7:S0140-6736(23)02760-5. doi: 10.1016/S0140-6736(23)02760.
    PubMed    
    
    
    February 2024
42. LEE ZS, Ryan N
    Intravascular imaging in percutaneous coronary intervention.
    Lancet. 2024 Feb 21:S0140-6736(23)02686-7. doi: 10.1016/S0140-6736(23)02686.
    PubMed    
    
    
    
43. STONE GW, Christiansen EH, Ali ZA, Andreasen LN, et al
    Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis.
    Lancet. 2024 Feb 21:S0140-6736(23)02454-6. doi: 10.1016/S0140-6736(23)02454.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diagnostic Imaging is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum